These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36677641)

  • 41. Alum-functionalized graphene oxide nanocomplexes for effective anticancer vaccination.
    Wang X; Cao F; Yan M; Liu Y; Zhu X; Sun H; Ma G
    Acta Biomater; 2019 Jan; 83():390-399. PubMed ID: 30448435
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Relationship between tightness of binding and immunogenicity in an aluminum-containing adjuvant-adsorbed hepatitis B vaccine.
    Egan PM; Belfast MT; Giménez JA; Sitrin RD; Mancinelli RJ
    Vaccine; 2009 May; 27(24):3175-80. PubMed ID: 19446188
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Change in the degree of adsorption of proteins by aluminum-containing adjuvants following exposure to interstitial fluid: freshly prepared and aged model vaccines.
    Shi Y; HogenEsch H; Hem SL
    Vaccine; 2001 Oct; 20(1-2):80-5. PubMed ID: 11567749
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relationship between physical and chemical properties of aluminum-containing adjuvants and immunopotentiation.
    Hem SL; Hogenesch H
    Expert Rev Vaccines; 2007 Oct; 6(5):685-98. PubMed ID: 17931150
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Insight into the cellular fate and toxicity of aluminium adjuvants used in clinically approved human vaccinations.
    Mold M; Shardlow E; Exley C
    Sci Rep; 2016 Aug; 6():31578. PubMed ID: 27515230
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Detoxification of endotoxin by aluminum hydroxide adjuvant.
    Shi Y; HogenEsch H; Regnier FE; Hem SL
    Vaccine; 2001 Feb; 19(13-14):1747-52. PubMed ID: 11166900
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Aluminum Hydroxide And Aluminum Phosphate Adjuvants Elicit A Different Innate Immune Response.
    Kooijman S; Vrieling H; Verhagen L; de Ridder J; de Haan A; van Riet E; Heck AJR; Kersten GFA; Pennings JLA; Metz B; Meiring HD
    J Pharm Sci; 2022 Apr; 111(4):982-990. PubMed ID: 35090866
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mg/Al-LDH as a nano-adjuvant for pertussis vaccine: a evaluation compared with aluminum hydroxide adjuvant.
    Li D; Xu M; Li G; Zheng Y; Zhang Y; Xia D; Wang S; Chen Y
    Nanotechnology; 2022 Mar; 33(23):. PubMed ID: 35189608
    [No Abstract]   [Full Text] [Related]  

  • 49. Aluminum hydroxide nanoparticles show strong activity to stimulate Th-1 immune response against tuberculosis.
    Amini Y; Moradi B; Fasihi-Ramandi M
    Artif Cells Nanomed Biotechnol; 2017 Nov; 45(7):1331-1335. PubMed ID: 27647321
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mechanism of adsorption of three recombinant Streptococcus pneumoniae (Sp) vaccine antigens by an aluminum adjuvant.
    Levesque PM; de Alwis U
    Hum Vaccin; 2005; 1(2):70-3. PubMed ID: 17038824
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nasal aluminum (oxy)hydroxide enables adsorbed antigens to induce specific systemic and mucosal immune responses.
    Xu H; Ruwona TB; Thakkar SG; Chen Y; Zeng M; Cui Z
    Hum Vaccin Immunother; 2017 Nov; 13(11):2688-2694. PubMed ID: 28933668
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An intrinsic fluorescence method for the determination of protein concentration in vaccines containing aluminum salt adjuvants.
    Nouchikian L; Roque C; Song JY; Rahman N; Ausar SF
    Vaccine; 2018 Sep; 36(38):5738-5746. PubMed ID: 30107994
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The importance of surface charge in the optimization of antigen-adjuvant interactions.
    Callahan PM; Shorter AL; Hem SL
    Pharm Res; 1991 Jul; 8(7):851-8. PubMed ID: 1924135
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of the strength of adsorption of HIV 1 SF162dV2gp140 to aluminum-containing adjuvants on the immune response.
    Hansen B; Malyala P; Singh M; Sun Y; Srivastava I; Hogenesch H; Hem SL
    J Pharm Sci; 2011 Aug; 100(8):3245-3250. PubMed ID: 21425166
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of phosphorylation of ovalbumin on adsorption by aluminum-containing adjuvants and elution upon exposure to interstitial fluid.
    Morefield GL; Jiang D; Romero-Mendez IZ; Geahlen RL; Hogenesch H; Hem SL
    Vaccine; 2005 Feb; 23(12):1502-6. PubMed ID: 15670886
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The immunogenicity of thin-film freeze-dried, aluminum salt-adjuvanted vaccine when exposed to different temperatures.
    Thakkar SG; Ruwona TB; Williams RO; Cui Z
    Hum Vaccin Immunother; 2017 Apr; 13(4):936-946. PubMed ID: 28051903
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of aluminum hydroxide adjuvant and formaldehyde in the formulation of rPA anthrax vaccine.
    Little SF; Ivins BE; Webster WM; Norris SL; Andrews GP
    Vaccine; 2007 Apr; 25(15):2771-7. PubMed ID: 17240008
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mechanisms of Antigen Adsorption Onto an Aluminum-Hydroxide Adjuvant Evaluated by High-Throughput Screening.
    Jully V; Mathot F; Moniotte N; Préat V; Lemoine D
    J Pharm Sci; 2016 Jun; 105(6):1829-1836. PubMed ID: 27238481
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Predicting the adsorption of proteins by aluminium-containing adjuvants.
    Seeber SJ; White JL; Hem SL
    Vaccine; 1991 Mar; 9(3):201-3. PubMed ID: 2042392
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vaccines with aluminum-containing adjuvants: optimizing vaccine efficacy and thermal stability.
    Clapp T; Siebert P; Chen D; Jones Braun L
    J Pharm Sci; 2011 Feb; 100(2):388-401. PubMed ID: 20740674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.